(Q39428199)

11 September 2017

title

Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type? (English)

1 reference

11 September 2017

1 reference

Medina RA

1

1 reference

11 September 2017

Pugh JA

series ordinal

2

1 reference

11 September 2017

Monterrosa A

series ordinal

3

1 reference

11 September 2017

Cornell J

series ordinal

4

1 reference

11 September 2017

publication date

1 August 1996

1 reference

American Journal of Kidney Diseases

11 September 2017

published in

1 reference

11 September 2017

volume

28

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

226-234

1 reference

Mortality rates among dialysis patients in Medicare's End-Stage Renal Disease Program.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Excess incidence of treatment of end-stage renal disease in Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Results from the Canadian Renal Failure Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Mortality and causes of death in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Prognostic factors, models and related statistical problems in the survival of endstage renal disease patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Survival rates of 2,728 patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Mortality in dialysis patients: analysis of the causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

International criteria for the diagnosis of diabetes and impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

The sickness impact profile: validation of a health status measure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Discontinuation of dialysis therapy as a cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

Results of lower extremity amputations in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990306-6

7 January 2021

10.1016/S0272-6386(96)90306-6

Identifiers

DOI

1 reference

11 September 2017

1 reference